US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist

1.740
+0.050+2.96%

Close Feb 14 16:00 ET

1.730
-0.010-0.57%

Post 20:01 ET

281.12MMarket Cap1.57P/E (TTM)

Neumora Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neumora Therapeutics Q4 2024 Estimates Date

Currency：USDMar 3, 2025

	Estimate	YoY
Revenue	0	--
EPS	-0.42	+40.53%

Analyst Rating

Strong Buy

Feb 5, 2025

Neumora Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
Mar 3, 2025	2024/Q4	-- / 0.000	--
Nov 12, 2024	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

Mar 3, 20252024/Q4-- / 0.000--

Nov 12, 20242024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Neumora Therapeutics Earnings Reports

Neumora Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 16:24 ET

Neumora Therapeutics | 8-K: Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 12, 2024 09:31 ET

Neumora Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 6, 2024 16:07 ET

Neumora Therapeutics | 8-K: Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 6, 2024 07:19 ET